JEOL's joint paper published in Physical Review Letters
The study demonstrates momentum transfer from free electrons to planar samples, providing insights into electron-light interactions.
See the latest news and media coverage for JEOL. We track all announcements, press releases, and industry mentions in real time, all in one place.
Scientific, semiconductor, industrial, and medical equipment manufacturer
jeol.comLast updated
In short: JEOL launched advanced electron microscopes and AI-powered analytical systems while divesting its medical equipment business.
The study demonstrates momentum transfer from free electrons to planar samples, providing insights into electron-light interactions.
It enables recipe-based data acquisition, supports up to 12 specimens, and allows continuous analysis without operator intervention.
JEOL tops Japanese companies in 2025 Nature Index 'Count metric' for research paper contributions. It reflects broad engagement in cutting-edge fields.
High-resolution images can be constructed in a short time from a small number of measurement points. Applications in high-speed, low-dose observation and semiconductor development are expected.
[Decreased Revenue and Profit] For the fiscal year ending March 2027, revenue declined due to the transfer of its "medical equipment business," including biochemical automatic analyzers for blood analysis, to Sysmex, as well as the impact of U.S. government cuts to science and technology budgets. Increased sales and administrative expenses also led to a decline in final profit. We will send newsletters and campaign information for Nikkei Electronic Edition to the email address you registered with (you can unsubscribe after registration). The email address will be used solely for these email distribution purposes. Other than that...
Jeol stock reflects the Japanese technology group’s earnings recovery and stabilizing demand for electron microscopes and analytical instruments, with investors watching margins, orders, and cash...
Regarding JEOL Ltd. <6951>, listed on the TSE Prime Market, Orbis Investment Management Limited filed a change report (5% rule report) with the Financial Services Bureau on July 7, 2026. The reason for filing is that the shareholding ratio increased by 1% or more.
JEOL recently reported solid fiscal 2024 results and outlined a cautious but constructive outlook supported by demand from semiconductor and life-science customers. We look at...
Track JEOL and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to JEOL and other trending companies.